25K0

25K0

Healthcare · EUR · F

25K0

Price

€6.677

+1.97%

Cap

€194.84M

Earnings

30d Trend

-12.6%

25K0
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityHigh

92% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level85
Quality49
Momentum88
Technical59
Fundamentals50

Raw weighted: 58×Macro 0.99 (1%)=57

RISK

85/100
90d Volatility
92.3%High
ATR %
8.1%High daily moves
Max Drawdown (1Y)
-48.4%Volatile

QUALITY

49/100
Piotroski F-Score
4/9Average
Accruals
-111.3%Cash earnings

MOMENTUM

88/100
12-1M Momentum
+92.7%Strong uptrend
6-1M Momentum
+53.6%Positive
1M Return
+8.5%Strong recent gains

TECHNICAL

59/100
RSI (14)
58.8Neutral
Price vs SMA200
+29.2%Bullish trend
MACD
+0.05Bullish momentum
Bollinger Band
72%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.117Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months57
3-12 months73
1-5+ years49

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate 25K0 at 57/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 88/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

+8.5%

3 MONTHS

-3.2%

12 MONTHS

+101.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (88) and Technical (59) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 92%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 57/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.